Medco Study Suggests Genetic Testing Improves Patient Compliance with Statins | GenomeWeb

By Turna Ray

Medco Health Solutions said last week that preliminary data from a study conducted in collaboration with Quest Diagnostics indicates that patients taking statins are more likely to take their medications if they have been genetically tested for the KIF6 marker.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.